The Global Genotyping Market report for by Product (reagents & kits, genotyping services, instruments and others), by technology (microarrays, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, maldi-tof, allele specific oligonucleotide (ASO) probes and others), by End user (pharmaceutical & biopharmaceutical companies, diagnostic & research laboratories and academic institutes), by geography (North America, Europe, Asia Pacific, Middle East & Africa and South America)) is expected to reach US $ XX Bn by 2027, at a CAGR of XX %.
The reagents and kits segment is expected to grow at a XX % rate of CAGR during the forecast period.
The reagents and kits segment held the US $ XX Mn market share in 2019 because of its wide usage rate and rise in demand for the genotyping tests. The reagents and kits segment is expected to grow at a XX % rate of CAGR during the forecast period owing to its wide usage of the application in the R&D laboratories and the presence of favorable funding programs. An introduction of innovative reagents like PCR cleanup reagents, SBE and ExoSAP-IT PCR products are also contributing a significant share in the market.
North America held the dominant position in the global genotyping market.
By region, Global Genotyping Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. Among these, the North American region is projected to grow at a XX % rate of CAGR during the forecast period. The presence of the well-established healthcare infrastructure and technology developments in the region are contributing to the significant share in the global market. An increase in awareness among people about personalized medicines and demand for products and services genetic testing is expected to boost the growth in the market. Furthermore, the Asia Pacific region is expected to grow at a XX % rate during the forecast period. Growth in economic stability, an introduction of favorable healthcare reforms, the disposable income, are some of the untapped market opportunities, which are expected to contribute significant share in the market.
Key players operating in the Global Genotyping Market includes GE Healthcare GmbH, Illumina, Inc., Beckman Coulter, Inc., Life Technologies Corporation, ThermoFisher Scientific, Inc., Eurofins Scientific, Qiagen NV, Roche Diagnostics, Affymetrix, Inc., Agilent Technologies, Inc., Genewiz, Inc., Fludigm Corporation, Bio-Rad Laboratories, INC. and Sequenom, Inc.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the Global Genotyping Market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the Global Genotyping Market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain Global Genotyping Market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Genotyping Market”
https://www.maximizemarketresearch.com/market-report/global-genotyping-market/52834/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, VadgaonBk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607065656